The differences in thrombolytic effects of administrated recombinant t-PA between Japanese and Caucasians

被引：62

作者：

Ueshima, S ^{[1
]}

Matsuo, O ^{[1
]}

机构：

[1] Kinki Univ, Sch Med, Dept Physiol, Osaka 5898511, Japan

来源：

THROMBOSIS AND HAEMOSTASIS | 2002年 / 87卷 / 03期

关键词：

D O I：

10.1055/s-0037-1613042

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：544 / 546

页数：3

共 16 条

[1] TNK tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction - Results of the TIMI 10B trial [J].

Cannon, CP ;

Gibson, CM ;

McCabe, CH ;

Adgey, AAJ ;

Schweiger, MJ ;

Sequeira, RF ;

Grollier, G ;

Giugliano, RP ;

Frey, M ;

Mueller, HS ;

Steingart, RM ;

Weaver, WD ;

Van de Werf, F ;

Braunwald, E .

CIRCULATION, 1998, 98 (25) :2805-2814

[2] RANDOMIZED ANGIOGRAPHIC TRIAL OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR (ALTEPLASE) IN MYOCARDIAL-INFARCTION [J].

CARNEY, RJ ;

MURPHY, GA ;

BRANDT, TR ;

DALEY, PJ ;

PICKERING, E ;

WHITE, HJ ;

MCDONOUGH, TJ ;

VERMILYA, SK ;

TEICHMAN, SL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (01) :17-23

[3] Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction -: A double-blind, randomized angiographic trial of lanoteplase versus alteplase [J].

den Heijer, P ;

Vermeer, F ;

Ambrosioni, E ;

Sadowski, Z ;

López-Sendón, JL ;

von Essen, R ;

Beaufils, P ;

Thadani, U ;

Adgey, J ;

Pierard, L ;

Brinker, J ;

Davies, RF ;

Smalling, RW ;

Wallentin, L ;

Caspi, A ;

Pangerl, A ;

Trickett, L ;

Hauck, C ;

Henry, D ;

Chew, P .

CIRCULATION, 1998, 98 (20) :2117-2125

[4] PLASMA-FIBRINOGEN AND ITS CORRELATES IN JAPANESE AND UNITED-STATES POPULATION SAMPLES [J].

ISO, H ;

FOLSOM, AR ;

SATO, S ;

WU, KK ;

SHIMAMOTO, T ;

KOIKE, K ;

IIDA, M ;

KOMACHI, Y .

ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (06) :783-790

[5]

ISO H, 1993, THROMB HAEMOSTASIS, V70, P475

[6] The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity [J].

Kangsadalampai, S ;

Board, PG .

BLOOD, 1998, 92 (08) :2766-2770

[7] THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) COMPARATIVE-STUDIES OF CORONARY REPERFUSION AND SYSTEMIC FIBRINOGENOLYSIS WITH 2 FORMS OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].

MUELLER, HS ;

RAO, AK ;

FORMAN, SA .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (03) :479-490

[8] Genetic polymorphisms associated with thrombotic disorders in the Japanese population [J].

Murata, M .

FIBRINOLYSIS & PROTEOLYSIS, 2000, 14 (2-3) :155-164

[9] IMPROVED THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION WITH FRONT-LOADED ADMINISTRATION OF ALTEPLASE - RESULTS OF THE RT-PA APSAC PATENCY STUDY (TAPS) [J].

NEUHAUS, KL ;

VONESSEN, R ;

TEBBE, U ;

VOGT, A ;

ROTH, M ;

RIESS, M ;

NIEDERER, W ;

FORYCKI, F ;

WIRTZFELD, A ;

MAEURER, W ;

LIMBOURG, P ;

MERX, W ;

HAERTEN, K .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (05) :885-891

[10]

NIITANI H, 1991, IGAKU NO AYUMI, V156, P429

← 1 2 →